Atabak Mokari
CIK 1678419 · Chief Financial Officer · last filed 2026-07-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.91M
Companies
3
Total Filings
31
Lifetime Open-Market Net
-$9.55M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CORT | Chief Financial Officer | 16,130 | $114.49 | $1.85M | -$9.55M | 22 | 2026-07-17 |
| BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted | Chief Financial Officer | — | $0.07 | — | $0 | 3 | 2020-04-09 |
| IRIX | CFO and VP Corp Development | 81,967 | $0.82 | $67.2K | $0 | 4 | 2018-12-13 |
Recent Filings · Page 2 of 4
31 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-03-04 | CORT | Mixed | +236 | -$108 | EDGAR |
| 2024-12-04 | CORT | Mixed | +280 | $3.2K | EDGAR |
| 2024-09-05 | CORT | Mixed | +657 | $8.7K | EDGAR |
| 2024-06-05 | CORT | Mixed | +2,325 | $28.1K | EDGAR |
| 2024-03-05 | CORT | Mixed | +591 | $890 | EDGAR |
| 2024-02-13 | CORT | Grant (A) | — | $0 | EDGAR |
| 2023-12-05 | CORT | Grant (A) | +1,016 | $13.2K | EDGAR |
| 2023-09-06 | CORT | Grant (A) | +796 | $13.2K | EDGAR |
| 2023-06-05 | CORT | Grant (A) | +3,302 | $37.9K | EDGAR |
| 2023-03-03 | CORT | Grant (A) | +2,520 | $25.0K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.